March 7, 2013
by Nobel Biocare
• Latest features reaffirm NobelClinician™ Software is the key to successful implant treatments
• New NobelReplace® Conical Connection and Replace Select™ implants increase treatment flexibility
• Innovative new features added to the iPad®-operated OsseoCare™ Pro drill motor
• Immediately loaded NobelActive® implants display a high cumulative survival rate in recent study
• Expert speakers discuss treatment planning, graftless edentulous solutions and CAD/CAM benefits
Nobel Biocare announces its latest innovations to the patient treatment workflow featuring new options for diagnostics and treatment planning as well as surgery at the Academy of Osseointegration Annual Meeting in Tampa, Florida, 7–9 March.
Nobel Biocare is the pioneer of the dental implant industry and a world leader in providing superior implantbased products and solutions that help dental professionals treat more patients better. New updates to the digital diagnostics and treatment planning NobelClinician Software include an enhanced technique that provides a new level of visibility and a new iPad® app to assist with more effective patient communication. To further accommodate all implant needs, the “Replace” implant family now has two new members adding a “partially machined collar” line extension to both NobelReplace Conical Connection and Replace Select Tapered.
The patient is at the forefront of Nobel Biocare’s mission, “Designing for Life,” an ambition to improve every patient’s quality of life with superior products and solutions designed to give functional and natural-looking tooth restorations that aspire to last a lifetime. For each core step of the patient treatment workflow – diagnostics and treatment planning, surgery, prosthetic estoration and post-treatment care – Nobel Biocare provides superior products and solutions to ensure maximum treatment safety, patient comfort and long-term success.
Latest features reaffirm NobelClinician™ Software is the key to successful implant treatments
NobelClinician provides precise implant planning options for predictable outcomes and is a very effective visual communication tool. As the first diagnostics and treatment planning software available for both Mac OS® X and Windows®, NobelClinician serves an increasing demand in the dental community as dental professionals frequently also use Apple® devices in their dental practices.
The latest version of NobelClinician Software significantly enhances diagnostic capabilities through a new 3D rendering technology called volume rendering. Clinicians can now instantly see below the surface of 3D bone models from (CB)CT patient scans and immediately identify and further inspect internal anatomical structures like tooth roots or previously-planned implants while treatment planning.
Dental professionals can now also use NobelClinician to import 2D images – like existing pre- and postoperative dental x-rays or clinical patient pictures (e.g. patient’s smile, intraoral clinical images, etc.) – and visualize them next to the 3D view. This allows the dental professional to be even closer to the real situation while virtually planning or discussing in an interdisciplinary treatment team and also considering availability of bone and prosthetic needs. All new views and pictures are fully integrated into the clinical report. Treatment scenarios can be shared securely and hassle-free through the NobelConnect collaboration feature to align computers within the practice or with other treating team members at different geographical locations.
The new and innovative NobelClinician Communicator iPad® app gives dental professionals a convenient platform to present and effectively communicate NobelClinician treatment plans to their patients. This revolutionary iPad® app can be used in a comfortable setting to easily display selected clinical pictures, x-rays and the patient’s 2D or 3D images for helping them to understand their treatment plan. The dental professional can use any iPad® with the NobelClinician Communicator app to open their NobelClinician patient presentations by just logging in with a NobelClinician user account. Additionally, the patient can confirm having seen and studied the information on the treatment flow by signing off on the iPad® presentation. The patient’s iPad® presentation is securely stored on the online NobelConnect space ensuring no information will be lost.
New NobelReplace® Conical Connection and Replace Select™ implants increase treatment flexibility
The line extension of partially machined collar implants featuring the new NobelReplace Conical Connection PMC and Replace Select Tapered PMC ensures that the original tapered implant system provides total patient treatment flexibility. No matter the patient requirements or clinician preference, NobelReplace and Replace Select represent one system for all clinical needs. The new NobelReplace Conical Connection PMC adds an additional option to the original with a 0.75 mm machined collar. NobelReplace Conical Connection combines the original tapered implant body with a sealed conical connection to offer dental professionals an esthetic solution for all indications. The body of all NobelReplace and Replace Select implants mimics the shape of a natural tooth root and is designed for high initial stability in all loading protocols including Immediate Function.
Replace Select Tapered – the safe, reliable and easy-to-use implant with the internal tri-channel connection – now offers two collar options for different clinical needs and treatment preferences. The original Replace Select Tapered has been available with a 1.5 mm machined collar for tissue-level restorations and the new Replace Select Tapered PMC is available with a 0.75 mm machined collar. The micro-roughness of the machined collar and abutment surface are similar to natural tooth enamel (Ra 0.3–0.5). These harmonious surface conditions promote optimal soft tissue attachment and a seal by the junctional epithelium for healthy and highly esthetic results.
Innovative new features added to the iPad®-operated OsseoCare™ Pro drill motor
The iPad®-operated OsseoCare Pro drill motor has added some new and innovative features to the latest application update now available in the Apple® App Store. New customizable drilling protocols allow users to create and save their own drilling protocols by changing or adding steps – both for Nobel Biocare and other implant systems. Additionally, OsseoCare Pro users can now use their handpiece of choice as well as switching between different contra-angles and handpiece ratios during surgery. Also, a new note-taking feature allows users to keep a more effective overview of surgery with the ability to add notes before, during and after surgery which can also be included in the reporting feature.
The intuitive user interface of the OsseoCare Pro combined with unique handling features provides clinicians and their patients with high treatment efficiency and security. Available free of charge from the Apple® App Store, the OsseoCare Pro pplication delivers highly user-friendly operations and opens up numerous avenues in terms of customization options.
Immediately loaded NobelActive® implants display a high cumulative survival rate in recent study
Since its launch five years ago, NobelActive has attracted new users at a pace the dental industry has not seen before – recently passing 1,000,000 NobelActive implants placed in patients worldwide. The most recent addition, NobelActive 3.0, provides narrow-fitting implant solutions and is specifically designed for the replacement
of single-unit maxillary lateral incisors as well as mandibular lateral and central incisors.
A new clinical study with three years of follow-up data confirms the exceptional performance of NobelActive. The study recently published in the European Journal of Oral Implantology entitled, “Comparison of variablethread tapered implant designs to a standard tapered implant design after immediate loading. A 3-year multicentre randomised controlled trial” aimed to verify whether immediate loading could be applied with NobelActive while achieving the same stable marginal bone levels and soft tissue healing as with the well-documented NobelReplace Tapered implant. After three years, the cumulative survival rate was 96–97%. Marginal bone levels were measured on intraoral radiographs and, after initial bone remodeling, demonstrated stable or improving levels during the second and third year. The mean papilla score increased significantly in all treatment groups.1
Expert speakers discuss treatment planning, graftless edentulous solutions and CAD/CAM benefits
Another exciting Nobel Biocare Corporate Forum will take place during the Academy of Osseointegration Annual Meeting on Thursday, 7 March, from 8:00 am to 12:00 pm. Topics include: “Proper treatment planning is the key to successful outcomes – Taking the step from 2D to 3D – Surgical & restorative considerations – Interactive case planning,” featuring an expert panel hosted by Dr. Peter Moy and Dr. Peter Wöhrle; “Bone regeneration protocols, techniques and materials – Where do we stand?” by Dr. Peter Moy and Dr. Sasha Jovanovic; “Maximizing the use of available bone by tilting implant concepts – Established procedures in favor of patients’ quality of life,” with Dr. Ivan Fortin; “Restorative considerations supporting edentulous to partially edentulous outcomes,” by Dr. Richard Sullivan and Dr. Markus Blatz; “Procedures for development of tissue stability and enhancing gingival papillae” with Dr. Sascha Jovanovic; and “Esthetic guidelines for ultimate success” by Dr. Markus Blatz.
Visit the Nobel Biocare at AO in booth #301 for more details and to experience the latest innovations in implantbased dentistry.
Nobel Biocare (NOBN, SIX Swiss Exchange) is a world leader in innovative restorative and esthetic dental solutions. As a complete solutions provider, Nobel Biocare offers the most comprehensive range of solutions from tooth to root, for single tooth to fully edentulous indications. The solutions portfolio covers dental implants (including the key brands NobelActive®, Brånemark System® and NobelReplace®, individualized prosthetics and equipment (NobelProcera®, guided surgery solutions and biomaterials). Nobel Biocare has approximately 2’500 employees and recorded revenue of EUR 580.5 million in 2012. The company is headquartered in Zurich, Switzerland. Production takes place at seven sites located in Canada, Israel, Japan, Sweden, and the US. Nobel Biocare has 34 direct sales organizations.